DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Wiviott SD, Raz I, Bonaca MP. et al.
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
New England Journal of Medicine 2019;
380: 347-357 . doi:10.1056/NEJMoa1812389
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.